We pride ourselves on delivering high-quality medical care while ensuring affordability is never compromised
Hormonal changes in perimenopause and menopause Perimenopause (typically 40-50): Estrogen fluctuations (up and down unpredictably) Progesterone decline begins Growth hormone (GH) production dropping Testosterone declining (yes, women need it too) Irregular periods and cycles Menopause (average age 51): Estrogen drops dramatically Progesterone nearly absent GH continues declining Metabolic rate slows 20-30% End of menstrual cycles Post-menopause (50+): Low estrogen becomes new baseline Further GH decline Muscle loss accelerates (sarcopenia) Bone density concerns Continued metabolic challenges Learn about peptides in our what are peptides guide , how peptides work , and what are peptides used for
2019: Rybelsus (semaglutide) received FDA approval to treat diabetes
Thereby, more use of models of inflammatory bowel disease (and in particular, more effectiveness in cysteamine colitis rats with colon-colon anastomosis), better evidence for multiple sclerosis models (especially, cuprizone application) would be ascertained
It created a pathway for bringing new drugs to market through FDA review, and it preserved a role for pharmacy compounding when patients have legitimate medical needs that commercial products can't meet
